References
1. Thormann K, Aubert H, Barbarot S, et al. Position statement on the role of nurses in therapeutic patient education in atopic dermatitis. J Eur Acad Dermatol Venereol. 2021;35(11):2143-2148. doi:10.1111/jdv.17487
2. Mohan GC, Lio PA. Comparison of Dermatology and Allergy Guidelines for Atopic Dermatitis Management. JAMA Dermatol. 2015;151(9):1009-1013. doi:10.1001/jamadermatol.2015.0250
3. Siegels D, Heratizadeh A, Abraham S, et al. Systemic treatments in the management of atopic dermatitis: A systematic review and meta-analysis. Allergy. 2021;76(4):1053-1076. doi:10.1111/all.14631
4. Young TK, Glick AF, Yin HS, et al. Management of Pediatric Atopic Dermatitis by Primary Care Providers: A Systematic Review. Acad Pediatr. 2021;21(8):1318-1327. doi:10.1016/j.acap.2021.07.008
5. Patruno C, Amerio P, Chiricozzi A, et al. Optimizing a clinical guidance for diagnosis of atopic dermatitis in adults: joint recommendations of the Italian Society of Dermatology and Venereology (SIDeMaST), Italian Association of Hospital Dermatologists (ADOI), and Italian Society of Allergological, Occupational and Environmental Dermatology (SIDAPA). G Ital Dermatol Venereol. 2020;155(1):1-7. doi:10.23736/S0392-0488.19.06522-2
6. de María Díaz Granados L, Quijano MA, Ramírez PA, Aguirre N, Sanclemente G. Quality assessment of atopic dermatitis clinical practice guidelines in ≤ 18 years. Arch Dermatol Res. 2018;310(1):29-37. doi:10.1007/s00403-017-1791-7
7. Mao W, Mao J, Zhang J, Wang L, Cao D, Qu Y. Atopic eczema: a disease modulated by gene and environment. Front Biosci (Landmark Ed). 2014;19(4):707-717. Published 2014 Jan 1. doi:10.2741/4237
8. Kim JE, Kim JS, Cho DH, Park HJ. Molecular Mechanisms of Cutaneous Inflammatory Disorder: Atopic Dermatitis. Int J Mol Sci. 2016;17(8):1234. Published 2016 Jul 30. doi:10.3390/ijms17081234
9. Danso MO, van Drongelen V, Mulder A, et al. TNF-α and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents. J Invest Dermatol. 2014;134(7):1941-1950. doi:10.1038/jid.2014.83
10. Czarnowicki T, Esaki H, Gonzalez J, et al. Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets. J Allergy Clin Immunol. 2015;136(4):941-951.e3. doi:10.1016/j.jaci.2015.05.049
11. Bieber T. Atopic dermatitis. N Engl J Med. 2008;358(14):1483-1494. doi:10.1056/NEJMra074081
12. Lack G. Clinical practice. Food allergy. N Engl J Med. 2008;359(12):1252-1260. doi:10.1056/NEJMcp0800871
13. De Benedetto A, Agnihothri R, McGirt LY, Bankova LG, Beck LA. Atopic dermatitis: a disease caused by innate immune defects?. J Invest Dermatol. 2009;129(1):14-30. doi:10.1038/jid.2008.259
14. Niebuhr M, Werfel T. Innate immunity, allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol. 2010;10(5):463-468. doi:10.1097/ACI.0b013e32833e3163
15. Narla S, Silverberg JI. Dermatology for the internist: optimal diagnosis and management of atopic dermatitis. Ann Med. 2021;53(1):2165-2177. doi:10.1080/07853890.2021.2004322
16. Nuttall TJ, Marsella R, Rosenbaum MR, Gonzales AJ, Fadok VA. Update on pathogenesis, diagnosis, and treatment of atopic dermatitis in dogs. J Am Vet Med Assoc. 2019;254(11):1291-1300. doi:10.2460/javma.254.11.1291
17. Akan A, Dibek-Mısırlıoğlu E, Civelek E, Vezir E, Kocabaş CN. Diagnosis of atopic dermatitis in children: comparison of the Hanifin-Rajka and the United Kingdom Working Party criteria. Allergol Immunopathol (Madr). 2020;48(2):175-181. doi:10.1016/j.aller.2019.07.008
18. Vakharia PP, Chopra R, Silverberg JI. Systematic Review of Diagnostic Criteria Used in Atopic Dermatitis Randomized Controlled Trials. Am J Clin Dermatol. 2018;19(1):15-22. doi:10.1007/s40257-017-0299-4
19. Langan SM, Irvine AD, Weidinger S. Atopic dermatitis [published correction appears in Lancet. 2020 Sep 12;396(10253):758]. Lancet. 2020;396(10247):345-360. doi:10.1016/S0140-6736(20)31286-1
20. Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839-E842. doi:10.1503/cmaj.090449
21. Werfel T, Heratizadeh A, Aberer W, et al. S2k guideline on diagnosis and treatment of atopic dermatitis–short version. J Dtsch Dermatol Ges. 2016;14(1):92-106. doi:10.1111/ddg.12871
22. Galli E, Neri I, Ricci G, et al. Consensus Conference on Clinical Management of pediatric Atopic Dermatitis. Ital J Pediatr. 2016;42:26. Published 2016 Mar 2. doi:10.1186/s13052-016-0229-8
23. Wong ITY, Tsuyuki RT, Cresswell-Melville A, Doiron P, Drucker AM. Guidelines for the management of atopic dermatitis (eczema) for pharmacists. Can Pharm J (Ott). 2017;150(5):285-297. Published 2017 May 30. doi:10.1177/1715163517710958
24. Boguniewicz M, Alexis AF, Beck LA, et al. Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies. J Allergy Clin Immunol Pract. 2017;5(6):1519-1531. doi:10.1016/j.jaip.2017.08.005
25. Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I [published correction appears in J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1436]. J Eur Acad Dermatol Venereol. 2018;32(5):657-682. doi:10.1111/jdv.14891
26. Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018;32(6):850-878. doi:10.1111/jdv.14888
27. Katoh N, Ohya Y, Ikeda M, et al. Clinical practice guidelines for the management of atopic dermatitis 2018. J Dermatol. 2019;46(12):1053-1101. doi:10.1111/1346-8138.15090
28. Chow S, Seow CS, Dizon MV, et al. A clinician’s reference guide for the management of atopic dermatitis in Asians. Asia Pac Allergy. 2018;8(4):e41. Published 2018 Oct 29. doi:10.5415/apallergy.2018.8.e41
29. Kent KA, Clark CA. Skin Deep: Simplifying Practice Guidelines for Children With Atopic Dermatitis. J Pediatr Health Care. 2018;32(5):507-514. doi:10.1016/j.pedhc.2018.06.001
30. Malaysian Health Technology Assessment Section (MaHTAS). Management of atopic eczema. 2018;http://www.dermatology.org.my/pdf/CPG_Management_of_Atopic_Eczema.pdf.
31. Aoki V, Lorenzini D, Orfali RL, et al. Consensus on the therapeutic management of atopic dermatitis - Brazilian Society of Dermatology. An Bras Dermatol. 2019;94(2 Suppl 1):67-75. doi:10.1590/abd1806-4841.2019940210
32. Damiani G, Calzavara-Pinton P, Stingeni L, et al. Italian guidelines for therapy of atopic dermatitis-Adapted from consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) [published correction appears in Dermatol Ther. 2021 Sep;34(5):e15091]. Dermatol Ther. 2019;32(6):e13121. doi:10.1111/dth.13121
33. Chiricozzi A, Belloni Fortina A, Galli E, et al. Current therapeutic paradigm in pediatric atopic dermatitis: Practical guidance from a national expert panel. Allergol Immunopathol (Madr). 2019;47(2):194-206. doi:10.1016/j.aller.2018.06.008
34. Rajagopalan M, De A, Godse K, et al. Guidelines on Management of Atopic Dermatitis in India: An Evidence-Based Review and an Expert Consensus. Indian J Dermatol. 2019;64(3):166-181. doi:10.4103/ijd.IJD_683_18
35. Katoh N, Ohya Y, Ikeda M, et al. Japanese guidelines for atopic dermatitis 2020. Allergol Int. 2020;69(3):356-369. doi:10.1016/j.alit.2020.02.006
36. Chan TC, Wu NL, Wong LS, et al. Taiwanese Dermatological Association consensus for the management of atopic dermatitis: A 2020 update. J Formos Med Assoc. 2021;120(1 Pt 2):429-442. doi:10.1016/j.jfma.2020.06.008
37. Atopic Dermatitis Working Group, Immunology Group, Chinese Society of Dermatology. Chinese guideline for diagnosis and treatment of atopic dermatitis (2020). Chinese Journal of Dermatology. 2020;53(2), 81-88.
38. Lee JH, Kim JE, Park GH, et al. Consensus Update for Systemic Treatment of Atopic Dermatitis. Ann Dermatol. 2021;33(6):497-514. doi:10.5021/ad.2021.33.6.497
39. Standardization project group of Clinical Application Guide for Dominant Diseases of Chinese Patent Medicine Treatment. International Clinical Practice Guidelines in Traditional Chinese Medicine: Atopic Dermatitis. Chinese Journal of Integrated Traditional and Western Medicine. 2020;41(2), 133-142.
40. Kulthanan K, Tuchinda P, Nitiyarom R, et al. Clinical practice guidelines for the diagnosis and management of atopic dermatitis. Asian Pac J Allergy Immunol. 2021;39(3):145-155. doi:10.12932/AP-010221-1050
41. Weil C, Sugerman PB, Chodick G, et al. Epidemiology and Economic Burden of Atopic Dermatitis: Real-World Retrospective Data from a Large Nationwide Israeli Healthcare Provider Database [published online ahead of print, 2022 Mar 29]. Adv Ther. 2022;10.1007/s12325-022-02120-6. doi:10.1007/s12325-022-02120-6
42. Abuabara K, Yu AM, Okhovat JP, Allen IE, Langan SM. The prevalence of atopic dermatitis beyond childhood: A systematic review and meta-analysis of longitudinal studies. Allergy. 2018;73(3):696-704. doi:10.1111/all.13320
43. Katibi OS, Cork MJ, Flohr C, Danby SG. Moisturizer therapy in prevention of atopic dermatitis and food allergy: To use or disuse?. Ann Allergy Asthma Immunol. 2022;S1081-1206(22)00124-7. doi:10.1016/j.anai.2022.02.012
44. Cacciapuoti S, Luciano MA, Megna M, et al. The Role of Thermal Water in Chronic Skin Diseases Management: A Review of the Literature. J Clin Med. 2020;9(9):3047. Published 2020 Sep 22. doi:10.3390/jcm9093047
45. Blauvelt A, de Bruin-Weller M, Gooderham M, et al. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Lancet. 2017;389(10086):2287-2303. doi:10.1016/S0140-6736(17)31191-1
46. de Bruin-Weller M, Thaçi D, Smith CH, et al. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ). Br J Dermatol. 2018;178(5):1083-1101. doi:10.1111/bjd.16156
47. Agache I, Akdis CA, Akdis M, et al. EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitis. Allergy. 2021;76(4):988-1009. doi:10.1111/all.14690
48. Wojcikowski K, Johnson DW, Gobé G. Medicinal herbal extracts – renal friend or foe? Part one: the toxicities of medicinal herbs. Nephrology (Carlton). 2004;9(5):313-318. doi:10.1111/j.1440-1797.2004.00310.x
49. Kojima R, Fujiwara T, Matsuda A, et al. Factors associated with steroid phobia in caregivers of children with atopic dermatitis. Pediatr Dermatol. 2013;30(1):29-35. doi:10.1111/j.1525-1470.2012.01808.x